Interleukin-17B Antagonizes Interleukin-25-Mediated Mucosal Inflammation

Immunity

Volumn 42, Issue 4, 2015, Pages 692-703

  Reynolds, Joseph M ^a   Lee, Young Hee ^b   Shi, Yun ^b   Wang, Xiaohu ^c   Angkasekwinai, Pornpimon ^d   Nallaparaju, Kalyan C ^b   Flaherty, Stephanie ^a   Chang, Seon Hee ^b   Watarai, Hiroshi ^e,f   Dong, Chen ^c  

^a ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c TSINGHUA UNIVERSITY   (China)

^d THAMMASAT UNIVERSITY   (Thailand)

^e UNIVERSITY OF TOKYO   (Japan)

^f JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 17; INTERLEUKIN 17 RECEPTOR; INTERLEUKIN 17 RECEPTOR B; INTERLEUKIN 17B; INTERLEUKIN 1BETA; INTERLEUKIN 25; INTERLEUKIN 6; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; D17WSU104E PROTEIN, MOUSE; DODECYL SULFATE SODIUM; IL17B PROTEIN, MOUSE; INTERLEUKIN DERIVATIVE; OVALBUMIN; PROTEIN BINDING;

ALLERGIC AIRWAY INFLAMMATION; ALLERGIC ASTHMA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CITROBACTER RODENTIUM; CITROBACTER RODENTIUM INFECTION; COLITIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; ENTEROBACTERIACEAE INFECTION; EPITHELIUM CELL; HEK293 CELL LINE; HUMAN; HUMAN CELL; MOUSE; MUCOSA INFLAMMATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; TH2 CELL; UPREGULATION; ANIMAL; ASTHMA; C57BL MOUSE; CELL LINE; CHEMICALLY INDUCED; DEFICIENCY; DYSBIOSIS; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; INTESTINE MUCOSA; KNOCKOUT MOUSE; MICROBIOLOGY; PATHOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; ANTI-BACTERIAL AGENTS; ASTHMA; CELL LINE; CITROBACTER RODENTIUM; COLITIS; DYSBIOSIS; ENTEROBACTERIACEAE INFECTIONS; EPITHELIAL CELLS; GENE EXPRESSION REGULATION; INTERLEUKIN-17; INTERLEUKIN-6; INTERLEUKINS; INTESTINAL MUCOSA; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OVALBUMIN; PROTEIN BINDING; RECEPTORS, INTERLEUKIN-17; SIGNAL TRANSDUCTION; SODIUM DODECYL SULFATE;

EID: 84928210009     PISSN: 10747613     EISSN: 10974180     Source Type: Journal    
DOI: 10.1016/j.immuni.2015.03.008     Document Type: Article

References (58)

1. Angkasekwinai P., Park H., Wang Y.H., Wang Y.H., Chang S.H., Corry D.B., Liu Y.J., Zhu Z., Dong C. Interleukin 25 promotes the initiation of proallergic type 2 responses. J.Exp. Med. 2007, 204:1509-1517.
2. Angkasekwinai P., Chang S.H., Thapa M., Watarai H., Dong C. Regulation of IL-9 expression by IL-25 signaling. Nat. Immunol. 2010, 11:250-256.
3. Atreya R., Mudter J., Finotto S., Müllberg J., Jostock T., Wirtz S., Schütz M., Bartsch B., Holtmann M., Becker C., et al. Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in crohn disease and experimental colitis invivo. Nat. Med. 2000, 6:583-588.
4. Büning C., Genschel J., Weltrich R., Lochs H., Schmidt H. The interleukin-25 gene located in the inflammatory bowel disease (IBD) 4 region: no association with inflammatory bowel disease. Eur. J. Immunogenet. 2003, 30:329-333.
5. Camelo A., Barlow J.L., Drynan L.F., Neill D.R., Ballantyne S.J., Wong S.H., Pannell R., Gao W., Wrigley K., Sprenkle J., McKenzie A.N. Blocking IL-25 signalling protects against gut inflammation in a type-2 model of colitis by suppressing nuocyte and NKT derived IL-13. J.Gastroenterol. 2012, 47:1198-1211.
6. Caruso R., Sarra M., Stolfi C., Rizzo A., Fina D., Fantini M.C., Pallone F., MacDonald T.T., Monteleone G. Interleukin-25 inhibits interleukin-12 production and Th1 cell-driven inflammation in the gut. Gastroenterology 2009, 136:2270-2279.
7. Chang S.H., Park H., Dong C. Act1 adaptor protein is an immediate and essential signaling component of interleukin-17 receptor. J.Biol. Chem. 2006, 281:35603-35607.
8. Chang S.H., Reynolds J.M., Pappu B.P., Chen G., Martinez G.J., Dong C. Interleukin-17C promotes Th17 cell responses and autoimmune disease via interleukin-17 receptor E. Immunity 2011, 35:611-621.
9. Claudio E., Sønder S.U., Saret S., Carvalho G., Ramalingam T.R., Wynn T.A., Chariot A., Garcia-Perganeda A., Leonardi A., Paun A., et al. The adaptor protein CIKS/Act1 is essential for IL-25-mediated allergic airway inflammation. J.Immunol. 2009, 182:1617-1630.
10. Cupedo T., Crellin N.K., Papazian N., Rombouts E.J., Weijer K., Grogan J.L., Fibbe W.E., Cornelissen J.J., Spits H. Human fetal lymphoid tissue-inducer cells are interleukin 17-producing precursors to RORC+ CD127+ natural killer-like cells. Nat. Immunol. 2009, 10:66-74.
11. Dann S.M., Spehlmann M.E., Hammond D.C., Iimura M., Hase K., Choi L.J., Hanson E., Eckmann L. IL-6-dependent mucosal protection prevents establishment of a microbial niche for attaching/effacing lesion-forming enteric bacterial pathogens. J.Immunol. 2008, 180:6816-6826.
12. Dong C. Regulation and pro-inflammatory function of interleukin-17 family cytokines. Immunol. Rev. 2008, 226:80-86.
13. Elinav E., Strowig T., Kau A.L., Henao-Mejia J., Thaiss C.A., Booth C.J., Peaper D.R., Bertin J., Eisenbarth S.C., Gordon J.I., Flavell R.A. NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell 2011, 145:745-757.
14. Fallon P.G., Ballantyne S.J., Mangan N.E., Barlow J.L., Dasvarma A., Hewett D.R., McIlgorm A., Jolin H.E., McKenzie A.N. Identification of an interleukin (IL)-25-dependent cell population that provides IL-4, IL-5, and IL-13 at the onset of helminth expulsion. J.Exp. Med. 2006, 203:1105-1116.
15. Fort M.M., Cheung J., Yen D., Li J., Zurawski S.M., Lo S., Menon S., Clifford T., Hunte B., Lesley R., et al. IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies invivo. Immunity 2001, 15:985-995.
16. Furuta S., Jeng Y.M., Zhou L., Huang L., Kuhn I., Bissell M.J., Lee W.H. IL-25 causes apoptosis of IL-25R-expressing breast cancer cells without toxicity to nonmalignant cells. Sci. Transl. Med. 2011, 3:78ra31.
17. Gay J., Kokkotou E., O'Brien M., Pothoulakis C., Karalis K.P. Interleukin-6 genetic ablation protects from trinitrobenzene sulfonic acid-induced colitis in mice. Putative effect of antiinflammatory cytokines. Neuroimmunomodulation 2006, 13:114-121.
18. Grivennikov S., Karin E., Terzic J., Mucida D., Yu G.Y., Vallabhapurapu S., Scheller J., Rose-John S., Cheroutre H., Eckmann L., Karin M. IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. Cancer Cell 2009, 15:103-113.
19. Hu H., Brittain G.C., Chang J.H., Puebla-Osorio N., Jin J., Zal A., Xiao Y., Cheng X., Chang M., Fu Y.X., et al. OTUD7B controls non-canonical NF-κB activation through deubiquitination of TRAF3. Nature 2013, 494:371-374.
20. Huang C.K., Yang C.Y., Jeng Y.M., Chen C.L., Wu H.H., Chang Y.C., Ma C., Kuo W.H., Chang K.J., Shew J.Y., Lee W.H. Autocrine/paracrine mechanism of interleukin-17B receptor promotes breast tumorigenesis through NF-kappaB-mediated antiapoptotic pathway. Oncogene 2014, 33:2968-2977.
21. Ivanov I.I., Frutos Rde.L., Manel N., Yoshinaga K., Rifkin D.B., Sartor R.B., Finlay B.B., Littman D.R. Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine. Cell Host Microbe 2008, 4:337-349.
22. Kokubu T., Haudenschild D.R., Moseley T.A., Rose L., Reddi A.H. Immunolocalization of IL-17A, IL-17B, and their receptors in chondrocytes during fracture healing. J.Histochem. Cytochem. 2008, 56:89-95.
23. Kuestner R.E., Taft D.W., Haran A., Brandt C.S., Brender T., Lum K., Harder B., Okada S., Ostrander C.D., Kreindler J.L., et al. Identification of the IL-17 receptor related molecule IL-17RC as the receptor for IL-17F. J.Immunol. 2007, 179:5462-5473.
24. Lee J., Ho W.H., Maruoka M., Corpuz R.T., Baldwin D.T., Foster J.S., Goddard A.D., Yansura D.G., Vandlen R.L., Wood W.I., Gurney A.L. IL-17E, a novel proinflammatory ligand for the IL-17 receptor homolog IL-17Rh1. J.Biol. Chem. 2001, 276:1660-1664.
25. Li H., Chen J., Huang A., Stinson J., Heldens S., Foster J., Dowd P., Gurney A.L., Wood W.I. Cloning and characterization of IL-17Band IL-17C, two new members of the IL-17 cytokine family. Proc. Natl. Acad. Sci. USA 2000, 97:773-778.
26. Luperchio S.A., Schauer D.B. Molecular pathogenesis of Citrobacter rodentium and transmissible murine colonic hyperplasia. Microbes Infect. 2001, 3:333-340.
27. Mchenga S.S., Wang D., Li C., Shan F., Lu C. Inhibitory effect of recombinant IL-25 on the development of dextran sulfate sodium-induced experimental colitis in mice. Cell. Mol. Immunol. 2008, 5:425-431.
28. Moro K., Yamada T., Tanabe M., Takeuchi T., Ikawa T., Kawamoto H., Furusawa J., Ohtani M., Fujii H., Koyasu S. Innate production of T(H)2 cytokines by adipose tissue-associated c-Kit(+)Sca-1(+) lymphoid cells. Nature 2010, 463:540-544.
29. Neill D.R., Wong S.H., Bellosi A., Flynn R.J., Daly M., Langford T.K., Bucks C., Kane C.M., Fallon P.G., Pannell R., et al. Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature 2010, 464:1367-1370.
30. Owyang A.M., Zaph C., Wilson E.H., Guild K.J., McClanahan T., Miller H.R., Cua D.J., Goldschmidt M., Hunter C.A., Kastelein R.A., Artis D. Interleukin 25 regulates type 2 cytokine-dependent immunity and limits chronic inflammation in the gastrointestinal tract. J.Exp. Med. 2006, 203:843-849.
31. Price A.E., Liang H.E., Sullivan B.M., Reinhardt R.L., Eisley C.J., Erle D.J., Locksley R.M. Systemically dispersed innate IL-13-expressing cells in type 2 immunity. Proc. Natl. Acad. Sci. USA 2010, 107:11489-11494.
32. Qian Y., Liu C., Hartupee J., Altuntas C.Z., Gulen M.F., Jane-Wit D., Xiao J., Lu Y., Giltiay N., Liu J., et al. The adaptor Act1 is required for interleukin 17-dependent signaling associated with autoimmune and inflammatory disease. Nat. Immunol. 2007, 8:247-256.
33. Ramirez-Carrozzi V., Sambandam A., Luis E., Lin Z., Jeet S., Lesch J., Hackney J., Kim J., Zhou M., Lai J., et al. IL-17C regulates the innate immune function of epithelial cells in an autocrine manner. Nat. Immunol. 2011, 12:1159-1166.
34. Reynolds J.M., Angkasekwinai P., Dong C. IL-17 family member cytokines: regulation and function in innate immunity. Cytokine Growth Factor Rev. 2010, 21:413-423.
35. Reynolds J.M., Martinez G.J., Nallaparaju K.C., Chang S.H., Wang Y.H., Dong C. Cutting edge: regulation of intestinal inflammation and barrier function by IL-17C. J.Immunol. 2012, 189:4226-4230.
36. Rickel E.A., Siegel L.A., Yoon B.R., Rottman J.B., Kugler D.G., Swart D.A., Anders P.M., Tocker J.E., Comeau M.R., Budelsky A.L. Identification of functional roles for both IL-17RB and IL-17RA in mediating IL-25-induced activities. J.Immunol. 2008, 181:4299-4310.
37. Saenz S.A., Siracusa M.C., Perrigoue J.G., Spencer S.P., Urban J.F., Tocker J.E., Budelsky A.L., Kleinschek M.A., Kastelein R.A., Kambayashi T., et al. IL25 elicits a multipotent progenitor cell population that promotes T(H)2 cytokine responses. Nature 2010, 464:1362-1366.
38. Sanders A.J., Guo X., Mason M.D., Jiang W.G. IL-17B can impact on endothelial cellular traits linked to tumour angiogenesis. J.Oncol. 2010, 2010:817375.
39. Sawa S., Cherrier M., Lochner M., Satoh-Takayama N., Fehling H.J., Langa F., Di Santo J.P., Eberl G. Lineage relationship analysis of RORgammat+ innate lymphoid cells. Science 2010, 330:665-669.
40. Sawa S., Lochner M., Satoh-Takayama N., Dulauroy S., Bérard M., Kleinschek M., Cua D., Di Santo J.P., Eberl G. RORγt+ innate lymphoid cells regulate intestinal homeostasis by integrating negative signals from the symbiotic microbiota. Nat. Immunol. 2011, 12:320-326.
41. Schwarzenberger P., La Russa V., Miller A., Ye P., Huang W., Zieske A., Nelson S., Bagby G.J., Stoltz D., Mynatt R.L., et al. IL-17 stimulates granulopoiesis in mice: use of an alternate, novel gene therapy-derived method for invivo evaluation of cytokines. J.Immunol. 1998, 161:6383-6389.
42. Shi Y., Ullrich S.J., Zhang J., Connolly K., Grzegorzewski K.J., Barber M.C., Wang W., Wathen K., Hodge V., Fisher C.L., et al. A novel cytokine receptor-ligand pair. Identification, molecular characterization, and invivo immunomodulatory activity. J.Biol. Chem. 2000, 275:19167-19176.
43. Song X., Zhu S., Shi P., Liu Y., Shi Y., Levin S.D., Qian Y. IL-17RE is the functional receptor for IL-17C and mediates mucosal immunity to infection with intestinal pathogens. Nat. Immunol. 2011, 12:1151-1158.
44. Su J., Chen T., Ji X.Y., Liu C., Yadav P.K., Wu R., Yang P., Liu Z. IL-25 downregulates Th1/Th17 immune response in an IL-10-dependentmanner in inflammatory bowel disease. Inflamm. Bowel Dis. 2013, 19:720-728.
45. Tajima M., Wakita D., Noguchi D., Chamoto K., Yue Z., Fugo K., Ishigame H., Iwakura Y., Kitamura H., Nishimura T. IL-6-dependent spontaneous proliferation is required for the induction of colitogenic IL-17-producing CD8+ Tcells. J.Exp. Med. 2008, 205:1019-1027.
46. Takatori H., Kanno Y., Watford W.T., Tato C.M., Weiss G., Ivanov I.I., Littman D.R., O'Shea J.J. Lymphoid tissue inducer-like cells are an innate source of IL-17 and IL-22. J.Exp. Med. 2009, 206:35-41.
47. Tian E., Sawyer J.R., Largaespada D.A., Jenkins N.A., Copeland N.G., Shaughnessy J.D. Evi27 encodes a novel membrane protein with homology to the IL17 receptor. Oncogene 2000, 19:2098-2109.
48. Toy D., Kugler D., Wolfson M., Vanden Bos T., Gurgel J., Derry J., Tocker J., Peschon J. Cutting edge: interleukin 17 signals through a heteromeric receptor complex. J.Immunol. 2006, 177:36-39.
49. Watarai H., Sekine-Kondo E., Shigeura T., Motomura Y., Yasuda T., Satoh R., Yoshida H., Kubo M., Kawamoto H., Koseki H., Taniguchi M. Development and function of invariant natural killer Tcells producing T(h)2- and T(h)17-cytokines. PLoS Biol. 2012, 10:e1001255.
50. Wong C.K., Cheung P.F., Ip W.K., Lam C.W. Interleukin-25-induced chemokines and interleukin-6 release from eosinophils is mediated by p38 mitogen-activated protein kinase, c-Jun N-terminal kinase, and nuclear factor-kappaB. Am. J. Respir. Cell Mol. Biol. 2005, 33:186-194.
51. Wright J.F., Bennett F., Li B., Brooks J., Luxenberg D.P., Whitters M.J., Tomkinson K.N., Fitz L.J., Wolfman N.M., Collins M., et al. The human IL-17F/IL-17A heterodimeric cytokine signals through the IL-17RA/IL-17RC receptor complex. J.Immunol. 2008, 181:2799-2805.
52. Yamaguchi Y., Fujio K., Shoda H., Okamoto A., Tsuno N.H., Takahashi K., Yamamoto K. IL-17B and IL-17C are associated with TNF-alpha production and contribute to the exacerbation of inflammatory arthritis. J.Immunol. 2007, 179:7128-7136.
53. Yang X.O., Chang S.H., Park H., Nurieva R., Shah B., Acero L., Wang Y.H., Schluns K.S., Broaddus R.R., Zhu Z., Dong C. Regulation of inflammatory responses by IL-17F. J.Exp. Med. 2008, 205:1063-1075.
54. Yen D., Cheung J., Scheerens H., Poulet F., McClanahan T., McKenzie B., Kleinschek M.A., Owyang A., Mattson J., Blumenschein W., et al. IL-23 is essential for Tcell-mediated colitis and promotes inflammation via IL-17 and IL-6. J.Clin. Invest. 2006, 116:1310-1316.
55. You Z., DuRaine G., Tien J.Y., Lee C., Moseley T.A., Reddi A.H. Expression of interleukin-17B in mouse embryonic limb buds and regulation by BMP-7 and bFGF. Biochem. Biophys. Res. Commun. 2005, 326:624-631.
56. Zaph C., Du Y., Saenz S.A., Nair M.G., Perrigoue J.G., Taylor B.C., Troy A.E., Kobuley D.E., Kastelein R.A., Cua D.J., et al. Commensal-dependent expression of IL-25 regulates the IL-23-IL-17 axis in the intestine. J.Exp. Med. 2008, 205:2191-2198.
57. Zhao A., Urban J.F., Sun R., Stiltz J., Morimoto M., Notari L., Madden K.B., Yang Z., Grinchuk V., Ramalingam T.R., et al. Critical role of IL-25 in nematode infection-induced alterations in intestinal function. J.Immunol. 2010, 185:6921-6929.
58. Zheng Y., Valdez P.A., Danilenko D.M., Hu Y., Sa S.M., Gong Q., Abbas A.R., Modrusan Z., Ghilardi N., de Sauvage F.J., Ouyang W. Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat. Med. 2008, 14:282-289.